The Health Resources and Services Administration (HRSA) is offering a federal grant opportunity through the Sickle Cell Disease Regional Care Excellence (SoRCE) Program, aimed at improving the health outcomes of individuals with sickle cell disease (SCD). This program seeks to enhance access to care, improve the quality of treatment, and monitor quality of life indicators for approximately 100,000 people affected by SCD in the United States. Eligible applicants, including hospitals, clinics, and health centers with a minimum of five years of experience in SCD care, can apply for one of seven cooperative agreements, with funding ranging from $0 to $950,000, totaling an estimated $6,650,000 available for the program. Interested parties should note that applications must be submitted electronically by May 31, 2026, with awards expected to be announced by August 1, 2026; for further inquiries, contact MCHB at scdprograms@hrsa.gov or call 240-438-6795.